Organigram Holdings Inc. Ending Cash

Ending Cash of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Ending Cash growth rates and interactive chart.


Highlights and Quick Summary

  • Ending Cash for the quarter ending May 31, 2022 was $35.5 Million (a -342.11% decrease compared to previous quarter)
  • Year-over-year quarterly Ending Cash decreased by -1316.11%
  • Annual Ending Cash for 2021 was $43.7 Million (a 138.62% increase from previous year)
  • Annual Ending Cash for 2020 was $18.3 Million (a -48.98% decrease from previous year)
  • Annual Ending Cash for 2019 was $35.9 Million (a -16.81% decrease from previous year)
  • Twelve month Ending Cash ending May 31, 2022 was $97.3 Million (a 61.01% increase compared to previous quarter)
  • Twelve month trailing Ending Cash increased by 122.81% year-over-year
Trailing Ending Cash for the last four month:
31 May '22 28 Feb '22 30 Nov '21 31 Aug '21
$97.3 Million $60.4 Million $44.1 Million $43.7 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Ending Cash of Organigram Holdings Inc.

Most recent Ending Cashof OGI including historical data for past 10 years.

Interactive Chart of Ending Cash of Organigram Holdings Inc.

Organigram Holdings Inc. Ending Cash for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $35.49 $-14.66
2021 $79.38 $-2.92 $-1.37 $-30.96 $43.67
2020 $78.91 $-13.65 $0.76 $5.5 $18.3
2019 $25.68 $0.67 $25.84 $-13.69 $35.87
2018 $23.06 $43.12 $43.12

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic